Vertex Innovation Awards
Vertex Innovation Awards support clinical researchers working collaboratively on innovative cystic fibrosis research, with the goal of improving care for people living with the condition.
Funder: Vertex Pharmaceuticals
Due Dates: 2026 cycle (accepting applications; deadline not specified)
Funding Amounts: Up to US$750,000 each year to four selected projects
Summary: Supports innovative, collaborative clinical research to improve care for people living with cystic fibrosis.
Key Information: Projects must be led by individuals with an established career interest in cystic fibrosis.
Description
The Vertex Innovation Awards (VIAs), run by Vertex Pharmaceuticals, support innovative and collaborative clinical research intended to improve care for people living with cystic fibrosis (CF). The program welcomes clinical research applications from across the CF field, with innovation, collaboration, and improved care at the center of its purpose. An independent committee of experts outside Vertex reviews and selects projects.
The awards form part of Vertex’s broader support for scientific research, innovation, and initiatives that advance knowledge and care for people with CF and other serious diseases in its research focus areas. Within that wider funding activity, the VIAs focus specifically on collaborative clinical research in CF.
